期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | JOURNAL OF CLINICAL VIROLOGY LetPub Score 6.3
50 ratings
Rate
Reputation 7.5 Influence 5.1 Speed 7.0 | ||||||||||||||||||||
期刊簡稱 | J CLIN VIROL | ||||||||||||||||||||
ISSN | 1386-6532 | ||||||||||||||||||||
E-ISSN | 1873-5967 | ||||||||||||||||||||
h-index | 97 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 2.50%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | https://www.journals.elsevier.com/journal-of-clinical-virology | ||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/JCV | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Elsevier | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | NETHERLANDS | ||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||
創刊年 | 1998 | ||||||||||||||||||||
每年文章數 | 113每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 41.87% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1386-6532%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2 Month(s) 來自Elsevier的數據: Average 8.2 Week(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: About 50% | ||||||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 3.1 Week(s) | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[JOURNAL OF CLINICAL VIROLOGY] 的評論 | 撰寫評論 |
作者: gdzyb 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-14 22:22:49 評論於 Can this magazine have only one corresponding author?(0) 讚! | gdzyb |
作者: 云来秀真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-27 08:23:56 評論於 How long does it usually take for submissions to be accepted? Can anyone who has recently been accepted share their experience?(0) 讚! | 云来秀真 |
作者: 盼旋小郎君 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-01 10:10:05 評論於 Review speed: 2.0 | Submission hit rate: 25.0 Research focus: Emerging virus studies Experience sharing: Impact factor has increased, submissions are significantly more difficult to get accepted(0) 讚! | 盼旋小郎君 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:49:35 評論於 ORCID is the Open Researcher and Contributor ID for scholars. The ORCID ID is a unique and persistent academic identifier for contributors, distinguishing authors from other researchers and recording all their related research activities. It is necessary to log in to each author's account and make connections within the account information settings(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:29:57 評論於 Due to the various factors that can affect the efficacy of animal experiments or clinical treatments, unless the results clearly show a synergistic effect that significantly increases the sum of the effectiveness of each drug, it is generally referred to as an additive effect(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 22:03:31 評論於 How to add ORCID iD if it was not provided when the article was published?(0) 讚! | 平原文波 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 12:42:04 評論於 How to determine if two drugs are acting synergistically or additively?(0) 讚! | 北国博达 |
作者: 仲夏玛丽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-06-10 18:32:59 評論於 Can research on HPV be submitted to this journal?(0) 讚! | 仲夏玛丽 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 09:00:11 評論於 3% margin, hoping to maintain stability, a slight increase would be nice(0) 讚! | 凌霄高洁 |
作者: 从玉殿下 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-06-25 08:30:24 評論於 IF sliding all the way(0) 讚! | 从玉殿下 |
作者: 从玉殿下 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-09-24 08:36:52 評論於 Received, this magazine is relatively rigorous(0) 讚! | 从玉殿下 |
作者: 从玉殿下 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-07-05 22:01:35 評論於 Review speed: 2.0 sharing experience: Just received the email, minor revisions. Reviewers are very professional and responsible!(0) 讚! | 从玉殿下 |
作者: 从玉殿下 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-05-12 16:13:43 評論於 Submitted on 4/30, still with editor(0) 讚! | 从玉殿下 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-11-26 23:40:20 評論於 Submitted 5 days ago, currently under review. The manuscript will also be sent for external review(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-11-23 21:33:14 評論於 Editor invited looking forward(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-07-01 12:51:40 評論於 Too mysterious, it dropped a little more than last year. Can it maintain a 3-point lead next year? It doesn't seem reliable(0) 讚! | 凌霄高洁 |
作者: Dunn Felix 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-04-27 18:29:13 評論於 Review speed: 2.0 | Acceptance rate: 50.0 Experience sharing: 4.3 submission, 4.26 rejection. Submitted a short communication, the review speed was quite fast. The opinions raised by the two reviewers were similar(0) 讚! | Dunn Felix |
作者: 匿名 領域: 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2011-08-19 15:33:00 評論於 Journal Homepage URL: http://www.elsevier.com/wps/find ... ription#description(0) 讚! | 匿名 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2009-12-21 10:30:54 評論於 The letters to this magazine are really easy to submit, they are basically accepted overnight!(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us